---
document_datetime: 2023-09-21 21:30:12
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/teriparatide-sun-epar-all-authorised-presentations_en.pdf
document_name: teriparatide-sun-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7675003
conversion_datetime: 2025-12-28 09:26:43.863611
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) Number   | (Invented) name   | Strength    | Pharmaceutical Form    | Route of Administration   | Immediate Packaging                   | Content (concentration)   | Pack size         |
|------------------|-------------------|-------------|------------------------|---------------------------|---------------------------------------|---------------------------|-------------------|
| EU/1/22/1697/001 | Teriparatide SUN  | 20 µg/80 µl | Solution for injection | Subcutaneous use          | cartridge (glass) in a pre-filled pen | 2.4 ml                    | 1 pre-filled pen  |
| EU/1/22/1697/002 | Teriparatide SUN  | 20 µg/80 µl | Solution for injection | Subcutaneous use          | cartridge (glass) in a pre-filled pen | 2.4 ml                    | 3 pre-filled pens |